"Receptors, Dopamine D3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of dopamine D2 receptors that are highly expressed in the LIMBIC SYSTEM of the brain.
Descriptor ID |
D050637
|
MeSH Number(s) |
D12.776.543.750.670.300.400.500.249 D12.776.543.750.695.150.400.500.500 D12.776.543.750.720.330.400.500.249
|
Concept/Terms |
Receptors, Dopamine D3- Receptors, Dopamine D3
- Dopamine D3 Receptor
- Receptor, Dopamine-D3
- Dopamine-D3 Receptor
- Dopamine Receptor D3
- Dopamine D3 Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Dopamine D3".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Dopamine [D12.776.543.750.670.300.400]
- Receptors, Dopamine D2 [D12.776.543.750.670.300.400.500]
- Receptors, Dopamine D3 [D12.776.543.750.670.300.400.500.249]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Dopamine [D12.776.543.750.695.150.400]
- Receptors, Dopamine D2 [D12.776.543.750.695.150.400.500]
- Receptors, Dopamine D3 [D12.776.543.750.695.150.400.500.500]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Dopamine [D12.776.543.750.720.330.400]
- Receptors, Dopamine D2 [D12.776.543.750.720.330.400.500]
- Receptors, Dopamine D3 [D12.776.543.750.720.330.400.500.249]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Dopamine D3".
This graph shows the total number of publications written about "Receptors, Dopamine D3" by people in this website by year, and whether "Receptors, Dopamine D3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Dopamine D3" by people in Profiles.
-
Increased drinking after intra-striatal injection of the dopamine D2/D3 receptor agonist quinpirole in the rat. Psychopharmacology (Berl). 2012 Oct; 223(4):457-63.
-
An intrastriatal brain-derived neurotrophic factor infusion restores striatal gene expression in Bdnf heterozygous mice. Brain Struct Funct. 2010 Aug; 215(2):97-104.
-
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behav Pharmacol. 2008 Sep; 19(5-6):641-9.
-
Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice. Genes Brain Behav. 2008 Nov; 7(8):906-14.
-
Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem. 2007 Dec 07; 282(49):35842-54.
-
Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine. Eur J Pharmacol. 2001 Apr 27; 418(3):201-6.
-
Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist. J Pharmacol Exp Ther. 2000 Jun; 293(3):710-6.
-
Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists. Adv Pharmacol. 1998; 42:443-6.
-
Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology. 1995 Jul; 12(4):335-45.
-
Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology (Berl). 1994 Oct; 116(2):217-25.